Findex makes investment appointments

appointments

8 April 2015
| By Staff |
image
image
expand image

Non-aligned advice and accountancy group, Findex has announced key appointments to its investment committee.

The company announced that it had appointed former MLC Chief Investment Officer and independent financial adviser, Chris Condon, to the committee alongside former Optimix Chief Investment Officer, Emmanuel Calligeris.

Commenting on the appointments, Findex Group chief executive, Sprio Paule, noted that the followed on from the appointment of former UBS executive, Dr Stefano Cavaglia, as Head of Investment Research,

Paule said both Condon and Calligeris would bring great wisdom and a wealth of experience to the critical role of investment product evaluation.

"The Findex Group Investment Committee is at the heart of the Group's philosophy of non-alignment," he said.

Read more about:

AUTHOR

Recommended for you

sub-bgsidebar subscription

Never miss the latest news and developments in wealth management industry

MARKET INSIGHTS

GG

So shareholders lose a dividend plus have seen the erosion of value. Qantas decides to clawback remuneration from Alan ...

4 weeks 1 day ago
Denise Baker

This is why I left my last position. There was no interest in giving the client quality time, it was all about bumping ...

4 weeks 2 days ago
gonski

So the Hayne Royal Commission has left us with this. What a sad day for the financial planning industry. Clearly most ...

4 weeks 2 days ago

The decision whether to proceed with a $100 million settlement for members of the buyer of last resort class action against AMP has been decided in the Federal Court....

2 weeks 1 day ago

A former Brisbane financial adviser has been found guilty of 28 counts of fraud where his clients lost $5.9 million....

4 weeks 1 day ago

The Financial Advice Association Australia has addressed “pretty disturbing” instances where its financial adviser members have allegedly experienced “bullying” by produc...

3 weeks 2 days ago

TOP PERFORMING FUNDS